List of Treatments for Lymphoma

Adcetris (Brentuximab vedotin)

Overview
Adcetris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of lymphoma in adults including classical Hodgkin lymphoma, anaplastic large cell lymphoma,… read more

Adriamycin (Doxorubicin)

The Adriamyxin brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Adriamycin, also known by its drug name doxorubicin, is a prescription medication approved by…

Aliqopa (Copanlisib)

Overview
Aliqopa was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed follicular lymphoma. Aliqopa was withdrawn from the market in November 2023. Aliqopa was indicated in… read more

Allogeneic (donor) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more

Arranon (Nelarabine)

Overview
Arranon is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia. Arranon is indicated in cases where… read more

Arzerra (Ofatumumab)

Overview
Arzerra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Arzerra is often prescribed in combination with… read more

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is sometimes used to treat people with lymphoma. The purpose of a stem cell transplant in lymphoma is to compensate for higher doses of chemotherapy that will… read more

Beleodaq (Belinostat)

Overview
Beleodaq is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma that has relapsed or failed to respond to other drugs. Beleodaq is also referred… read more

Bendeka (Bendamustine Hydrochloride)

Overview
Bendeka is approved by the U.S. Food and Drug Administration (FDA) for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL) in people whose disease has progressed during or within six months of treatment…

Bexxar (Tositumomab and iodine I 131 tositumomab)

Overview
Bexxar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with CD20­-positive, relapsed or refractory, low-grade, follicular, or transformed non-Hodgkin's lymphoma… read more

BiCNU (Carmustine)

Overview
BiCNU, also known by its drug name, carmustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.… read more

Blenoxane (Bleomycin)

The Blenoxane brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Blenoxane is a prescription medication approved by the U.S. Food and Drug Administration (FDA)…

Blood transfusion

Overview
Lymphoma treatments including chemotherapy and radiation therapy can destroy bone marrow, making it impossible produce new blood cells. In people with some types of lymphoma, cancer cells can damage the bone… read more

Breyanzi (Lisocabtagene Maraleucel)

Overview
Breyanzi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL)…

Brukinsa (Zanubrutinib)

Overview
Brukinsa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with various types of lymphoma, including mantle cell lymphoma (MCL) for those who have received at least…

Calquence (Acalabrutinib)

Overview
Calquence is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with mantle cell lymphoma (MCL) who have received at least one prior treatment, or adults with chronic… read more

Chemotherapy

Overview
Chemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells. Some doctors may refer to all medication prescribed for someone with lymphoma as chemotherapy. Chemotherapy is… read more

Clinical trials

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for lymphoma. Clinical trials are the only way that new treatments for lymphoma can be tested.… read more

Columvi (Glofitamab-Gxbm)

Overview
Columvi is approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBLC) not otherwise specified or large B-cell lymphoma (LBCL) arising…

Complementary and integrative therapies

Overview
In a survey of 700 people living with lymphoma, approximately 90 percent had used complementary or alternative treatments. Complementary treatments are those used alongside standard medical treatments… read more

Copiktra (Duvelisib)

Overview
Copiktra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphomas including small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL), and… read more

Corticosteroids

Overview
Corticosteroids are a class of prescription drugs approved by the Food and Drug Administration (FDA) to treat inflammation. Corticosteroids are sometimes used to treat people with lymphoma.

The most common… read more

Cytoxan (Cyclophosphamide)

The Cytoxan brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Cytoxan, also known by its drug name, cyclophosphamide, is a prescription medication approved by…

DepoCyt (Cytarabine liposome)

Overview
DepoCyt is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain types of leukemia and lymphoma that have spread to the meninges – the layers of tissue that cover… read more

DTIC-Dome (Dacarbazine)

The DTIC-Dome brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

DTIC-Dome, also known by its drug name, dacarbazine, is a prescription medication approved by…

Epkinly (Epcoritamab-bysp)

Overview
Epkinly is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, in adults who have already… read more

Erwinaze (Asparaginase Erwinia chrysanthemi)

Overview
Erwinaze is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute lymphoblastic leukemia (ALL) who have developed an allergy to E. coli-derived asparaginase.… read more

Erythropoietin (EPO)

Overview
Erythropoietin is a hormone that stimulates red blood cell production in the bone marrow. Erythropoietin is secreted by the kidneys.

Anemia (low levels of red blood cells) is common in people with lymphoma… read more

Etoposide

Overview
Etoposide is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several types of cancer. It is sometimes used off-label to treat Hodgkin and non-Hodgkin lymphoma.… read more

Exercise

Overview
Regular physical activity has been shown to benefit people with lymphoma in many ways. Most importantly, exercise has been proven to help those diagnosed with lymphoma live longer. Exercise can also improve the… read more

Flu and pneumonia vaccinations

Overview
People who currently have or have had lymphoma and other cancers are at greater risk for severe infections and serious complications from influenza (the flu) and pneumonia.

The U.S. Centers for Disease… read more

Folotyn (Pralatrexate)

Overview
Folotyn is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat peripheral T-cell lymphoma (PTCL) that has relapsed or failed to respond to other drugs. Folotyn is also… read more

Gazyva (Obinutuzumab)

Overview
Gazyva is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma and chronic lymphocytic leukemia. Gazyva is often prescribed in combination with other drugs… read more

Gleostine (Lomustine)

Overview
Gleostine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma that has progressed after initial therapy. Gleostine is often combined with a… read more

Imbruvica (Ibrutinib)

Overview
Imbruvica is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat several types of non-Hodgkin lymphoma, including mantle cell lymphoma, chronic lymphocytic leukemia (CLL)/small… read more

Interferon

Overview
Interferon is a type of medication approved by the U.S. Food and Drug Administration (FDA) to modify the immune system and slow the growth of cancer cells in people 18 years of age or older with cutaneous… read more

Intravenous immunoglobulin (IVIG)

Overview
In some cases of chronic lymphocytic leukemia (CLL) and lymphoma, abnormal versions of white blood cells known as plasma B cells proliferate, crowding out healthy cells and forming tumors. Healthy plasma cells… read more

Istodax (Romidepsin)

Overview
Istodax is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma (PTCL). Istodax is indicated in cases where at… read more

Jaypirca (Pirtobrutinib))

Overview
Jaypirca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).… read more

Keytruda (Pembrolizumab)

Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Keytruda is indicated in… read more

Kymriah (Tisagenlecleucel)

Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Kymriah is indicated when lymphoma is relapsed or refractory and at least two… read more

Leukeran (Chlorambucil)

Overview
Leukeran is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), lymphosarcoma, and giant follicular lymphoma.… read more

Lunsumio (Mosunetuzumab-axgb)

Overview
Lunsumio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory follicular lymphoma who have already tried two types of systemic therapy.… read more

Lymphir (Denileukin Diftitox-Cxdl)

Overview
Lymphir is a biologic treatment approved by the U.S. Food and Drug Administration (FDA) for adults with relapsed or refractory stage 1 through stage 3 cutaneous T-cell lymphoma who have already received at least…

Matulane (Procarbazine)

Overview
Matulane is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat stage III and stage IV Hodgkin lymphoma. Matulane is part of the MOPP chemotherapy regimen in combination… read more

Medical marijuana

Overview
Medical marijuana, also known as medical cannabis, is widely used to treat chronic pain, nausea, vomiting, loss of appetite, and insomnia, all common symptoms of lymphoma or side effects of its treatment.… read more

Methotrexate

Overview
Methotrexate is a prescription drug approved by the Food and Drug Administration (FDA) to treat some types of cancer including non-Hodgkin lymphoma (NHL). Methotrexate is sold under brand names including… read more

Monjuvi (Tafasitamab-cxix)

Overview
Monjuvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with refractory or relapsed diffuse large B-cell lymphoma (DLBCL) not otherwise specified in people who are… read more

Mozobil (Plerixafor)

Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for use before autologous stem cell transplant in people with non-Hodgkin lymphoma and multiple myeloma. Mozobil is used in… read more

Mustargen (Mechlorethamine)

Overview
Mustargen is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat Hodgkin lymphoma in stages III and IV, chronic lymphocytic leukemia (CLL), mycosis fungoides,… read more